Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance
Identifieur interne : 006C72 ( Main/Exploration ); précédent : 006C71; suivant : 006C73Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance
Auteurs : Bontha V. Babu [Inde] ; Suchismita Mishra [Inde]Source :
- Transactions of The Royal Society of Tropical Medicine and Hygiene [ 0035-9203 ] ; 2008-12.
Descripteurs français
- KwdFr :
- Adulte, Attitude envers la santé, Enquêtes et questionnaires, Femelle, Filaricides (usage thérapeutique), Filariose lymphatique (), Filariose lymphatique (psychologie), Filariose lymphatique (traitement médicamenteux), Humains, Inde, Mâle, Observance du traitement médicamenteux (psychologie), Évaluation de programme ().
- Wicri :
- geographic : Inde.
- MESH :
- psychologie : Filariose lymphatique, Observance du traitement médicamenteux.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Filaricides.
- Adulte, Attitude envers la santé, Enquêtes et questionnaires, Femelle, Filariose lymphatique, Humains, Inde, Mâle, Évaluation de programme.
English descriptors
- KwdEn :
- Adult, Attitude to Health, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (prevention & control), Elephantiasis, Filarial (psychology), Female, Filaricides (therapeutic use), Humans, India, Lymphatic filariasis, Male, Mass drug administration, Medication Adherence (psychology), Patient compliance, Program Evaluation (methods), Qualitative data, Quantitative data, Surveys and Questionnaires.
- MESH :
- chemical , therapeutic use : Filaricides.
- geographic : India.
- drug therapy : Elephantiasis, Filarial.
- methods : Program Evaluation.
- prevention & control : Elephantiasis, Filarial.
- psychology : Elephantiasis, Filarial, Medication Adherence.
- Adult, Attitude to Health, Female, Humans, Male, Surveys and Questionnaires.
Abstract
The present study aimed to identify the factors responsible for compliance and non-compliance of mass drug administration (MDA) under the programme to eliminate lymphatic filariasis (LF) from Orissa, India. It was based on both quantitative (through household MDA coverage survey) and qualitative data (through semi-structured interviews with heads of compliant and non-compliant households) collected during an MDA held in November 2005 in two districts of Orissa. In these districts, 83% of the eligible population received the drug (coverage) and only 49.5% people actually consumed the drug (compliance). Seventeen percent of the population did not even receive the drug. The predominant reason for not receiving the drug at household level was that the drug distributor did not visit the household, while the fear of adverse reactions is the predominant reason for not consuming it. The qualitative data revealed that the major contributor to taking the drug was the awareness that drug protects them from LF. Motivation by health workers was another reason for compliance. In many endemic areas, the issues related to non-compliance were taken casually during implementation. Hence, it is imperative to make the programme more efficient by addressing the issues linked to low compliance.
Url:
DOI: 10.1016/j.trstmh.2008.05.023
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003737
- to stream Istex, to step Curation: 003737
- to stream Istex, to step Checkpoint: 000F31
- to stream PubMed, to step Corpus: 003196
- to stream PubMed, to step Curation: 003196
- to stream PubMed, to step Checkpoint: 003196
- to stream Ncbi, to step Merge: 002E41
- to stream Ncbi, to step Curation: 002E41
- to stream Ncbi, to step Checkpoint: 002E41
- to stream Main, to step Merge: 006D81
- to stream Main, to step Curation: 006C72
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance</title><author><name sortKey="Babu, Bontha V" sort="Babu, Bontha V" uniqKey="Babu B" first="Bontha V." last="Babu">Bontha V. Babu</name></author><author><name sortKey="Mishra, Suchismita" sort="Mishra, Suchismita" uniqKey="Mishra S" first="Suchismita" last="Mishra">Suchismita Mishra</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:75E1577165FAD05F131B1B9213BD87929E0EE5F1</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1016/j.trstmh.2008.05.023</idno><idno type="url">https://api.istex.fr/document/75E1577165FAD05F131B1B9213BD87929E0EE5F1/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003737</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003737</idno><idno type="wicri:Area/Istex/Curation">003737</idno><idno type="wicri:Area/Istex/Checkpoint">000F31</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000F31</idno><idno type="wicri:doubleKey">0035-9203:2008:Babu B:mass:drug:administration</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:18632125</idno><idno type="wicri:Area/PubMed/Corpus">003196</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003196</idno><idno type="wicri:Area/PubMed/Curation">003196</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003196</idno><idno type="wicri:Area/PubMed/Checkpoint">003196</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003196</idno><idno type="wicri:Area/Ncbi/Merge">002E41</idno><idno type="wicri:Area/Ncbi/Curation">002E41</idno><idno type="wicri:Area/Ncbi/Checkpoint">002E41</idno><idno type="wicri:Area/Main/Merge">006D81</idno><idno type="wicri:Area/Main/Curation">006C72</idno><idno type="wicri:Area/Main/Exploration">006C72</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance</title><author><name sortKey="Babu, Bontha V" sort="Babu, Bontha V" uniqKey="Babu B" first="Bontha V." last="Babu">Bontha V. Babu</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Regional Medical Research Centre, Indian Council of Medical Research, Bhubaneswar 751 023</wicri:regionArea><wicri:noRegion>Bhubaneswar 751 023</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Social and Behavioural Research Unit, Indian Council of Medical Research, New Delhi 110 029</wicri:regionArea><wicri:noRegion>New Delhi 110 029</wicri:noRegion></affiliation><affiliation></affiliation></author><author><name sortKey="Mishra, Suchismita" sort="Mishra, Suchismita" uniqKey="Mishra S" first="Suchismita" last="Mishra">Suchismita Mishra</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Regional Medical Research Centre, Indian Council of Medical Research, Bhubaneswar 751 023</wicri:regionArea><wicri:noRegion>Bhubaneswar 751 023</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Transactions of The Royal Society of Tropical Medicine and Hygiene</title><title level="j" type="abbrev">Trans R Soc Trop Med Hyg</title><idno type="ISSN">0035-9203</idno><idno type="eISSN">1878-3503</idno><imprint><publisher>Royal Society of Tropical Medicine and Hygiene</publisher><date type="published" when="2008-12">2008-12</date><biblScope unit="volume">102</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="1207">1207</biblScope><biblScope unit="page" to="1213">1213</biblScope></imprint><idno type="ISSN">0035-9203</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0035-9203</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Attitude to Health</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Elephantiasis, Filarial (psychology)</term><term>Female</term><term>Filaricides (therapeutic use)</term><term>Humans</term><term>India</term><term>Lymphatic filariasis</term><term>Male</term><term>Mass drug administration</term><term>Medication Adherence (psychology)</term><term>Patient compliance</term><term>Program Evaluation (methods)</term><term>Qualitative data</term><term>Quantitative data</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Attitude envers la santé</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (psychologie)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Inde</term><term>Mâle</term><term>Observance du traitement médicamenteux (psychologie)</term><term>Évaluation de programme ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Filaricides</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>India</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Program Evaluation</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Observance du traitement médicamenteux</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Medication Adherence</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Filaricides</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Attitude to Health</term><term>Female</term><term>Humans</term><term>Male</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Attitude envers la santé</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Inde</term><term>Mâle</term><term>Évaluation de programme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">The present study aimed to identify the factors responsible for compliance and non-compliance of mass drug administration (MDA) under the programme to eliminate lymphatic filariasis (LF) from Orissa, India. It was based on both quantitative (through household MDA coverage survey) and qualitative data (through semi-structured interviews with heads of compliant and non-compliant households) collected during an MDA held in November 2005 in two districts of Orissa. In these districts, 83% of the eligible population received the drug (coverage) and only 49.5% people actually consumed the drug (compliance). Seventeen percent of the population did not even receive the drug. The predominant reason for not receiving the drug at household level was that the drug distributor did not visit the household, while the fear of adverse reactions is the predominant reason for not consuming it. The qualitative data revealed that the major contributor to taking the drug was the awareness that drug protects them from LF. Motivation by health workers was another reason for compliance. In many endemic areas, the issues related to non-compliance were taken casually during implementation. Hence, it is imperative to make the programme more efficient by addressing the issues linked to low compliance.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><country name="Inde"><noRegion><name sortKey="Babu, Bontha V" sort="Babu, Bontha V" uniqKey="Babu B" first="Bontha V." last="Babu">Bontha V. Babu</name></noRegion><name sortKey="Babu, Bontha V" sort="Babu, Bontha V" uniqKey="Babu B" first="Bontha V." last="Babu">Bontha V. Babu</name><name sortKey="Mishra, Suchismita" sort="Mishra, Suchismita" uniqKey="Mishra S" first="Suchismita" last="Mishra">Suchismita Mishra</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006C72 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006C72 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:75E1577165FAD05F131B1B9213BD87929E0EE5F1
|texte= Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance
}}
| This area was generated with Dilib version V0.6.31. |  |